19 Results for "

O-GlcNAc transferase

" in MedChemExpress (MCE) Product Catalog:
Products (19)

19 Results for "O-GlcNAc transferase" in MCE Product Catalog:

51
51 Publications Verification
Cat. No.: HY-119738
CAS No.: 1681056-61-0
Purity:  99.90%
Target:  

OGT Acyltransferase

Research Areas:  

Metabolic Disease

OSMI-1 is a cell-permeable O-GlcNAc transferase (OGT) inhibitor with an IC50 value of 2.7 μM. OSMI-1 inhibits protein O-linked N-acetylglucosamine (O-GlcNAcylation) in several mammalian cell lines without qualitatively altering cell surface N- or O-linked glycans .
loading...
    loading...
32
32 Cited Publications
Cat. No.: HY-114361
CAS No.: 2260791-14-6
Purity:  99.69%
Target:  

OGT Acyltransferase

Research Areas:  

Metabolic Disease

OSMI-4 is a low nanomolar O-GlcNAc transferase (OGT) inhibitor, with an EC50 of 3 μM in cells.
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-112174
CAS No.: 91183-98-1
Purity:  99.92%
Synonyms: UDP-α-D-N-Acetylglucosamine disodium
Target:  

OGT

Research Areas:  

Metabolic Disease

UDP-GlcNAc Disodium Salt (UDP-α-D-N-Acetylglucosamine Disodium Salt) is a donor substrate of O-GlcNAc transferase (OGT).
loading...
    loading...
Cat. No.: HY-N3677
CAS No.: 14351-29-2
Dammarenediol II is a ginsenoside precursor . Dammarenediol II reduces the activity of O-GlcNAc transferase (OGT) and downregulates the global O-GlcNAcylation level. Dammarenediol II inhibits the phosphorylation of Akt, mTOR and GSK3β. Dammarenediol II inhibits human carboxylesterase activity, VEGF-induced ROS production, stress fiber formation and vascular endothelial cadherin disruption. Dammarenediol II promotes cell apoptosis (apoptosis), increases the levels of cleaved PARP1 and p53, and inhibits retinal microvascular leakage. Dammarenediol II can be used in studies related to liver cancer and diabetic retinopathy .
loading...
    loading...
Cat. No.: HY-148113
CAS No.: 1681056-62-1
Purity:  ≥98.0%
Target:  

OGT

Research Areas:  

Others

PG 34 is a weak O-GlcNAc transferase (OGT) inhibitor (IC50=68 μM), and a close structural analog of OSMI-1 (HY-119738) .
loading...
    loading...
Cat. No.: HY-139793
CAS No.: 1355005-51-4
Purity:  99.43%
UDP-glucosamine (UDP-GlcNAc) disodium is a substrate for O-GlcNAc transferase, which catalyzes the attachment of O-GlcNAc to proteins. O-GlcNAcase catalyzes the removal of O-GlcNAc from proteins. UDP-glucosamine (UDP-GlcNAc) disodium is the end product of the hexosamine biosynthesis pathway, which is regulated primarily by glucose-6-phosphate-Glutamine:fructose-6-phosphate amidotransferase (GFAT) .
loading...
    loading...
Cat. No.: HY-125278
CAS No.: 2411972-44-4
Target:  

OGT

Research Areas:  

Others

OGT-IN-4 (compound 4a) is an O-GlcNAc transferase (OGT) inhibitor with a Kd of 8 nM. OGT-IN-4 can be utilized in OGT related research .
loading...
    loading...
Cat. No.: HY-149552
CAS No.: 67561-97-1
Target:  

OGT

Research Areas:  

Cancer

Ac4-5SGlcNAc is an O-GlcNAc transferase (OGT) inhibitor. Ac4-5SGlcNAc converts intracellularly to UDP-5SGlcNAc, which competes with native UDP-GlcNAc (HY-148596) to block OGT catalytic activity, reduces cellular UDP-GlcNAc pools, and limits global protein O-GlcNAcylation. Ac4-5SGlcNAc reduces OGA levels via feedback, alters lectin signal intensities and glycan-related band masses. Ac4-5SGlcNAc can be used for the research of breast cancer .
loading...
    loading...
Cat. No.: HY-W039939
CAS No.: 56883-39-7
Synonyms: 2-ADG, 98%
2-Azido-2-deoxy-D-glucose, 98% (2-ADG, 98%) is a substrate of O-GlcNAc transferase (OGT). 2-Azido-2-deoxy-D-glucose, 98% can be transferred from UDP-GlcAz to proteins in vitro via OGT mediation. When delivered as AcGlcAz, 2-Azido-2-deoxy-D-glucose, 98% enables the labeling and investigation of O-GlcNAc-modified nuclear and cytoplasmic proteins in cells. 2-Azido-2-deoxy-D-glucose, 98% undergoes strain-promoted [3+2] azide-alkyne cycloaddition (SPAAC) with technetium- 99m-labeled dibenzocyclooctyne derivatives in vivo. 2-Azido-2-deoxy-D-glucose, 98% can be used in sarcoma-related research .
loading...
    loading...
Cat. No.: HY-101548
CAS No.: 371215-02-0
Purity:  98.14%
Target:  

OGT

Research Areas:  

Metabolic Disease

OGT-IN-1 (Compound 5) is a potent OGT inhibitor. OGT-IN-1 inhibits sOGT and ncOGT with IC50s of 27 and 10 μM, respectively .
loading...
    loading...
Cat. No.: HY-112174S
Purity:  96.99%
Synonyms: UDP-α-D-N-Acetylglucosamine-13C disodium
UDP-GlcNAc- 13C (disodium) is the 13C labeled UDP-GlcNAc Disodium Salt. UDP-GlcNAc Disodium Salt (UDP-α-D-N-Acetylglucosamine Disodium Salt) is a donor substrate of O-GlcNAc transferase (O .
loading...
    loading...
Cat. No.: HY-119738A
CAS No.: 2748153-92-4
Purity:  96.51%
Target:  

OGT Acyltransferase

Research Areas:  

Metabolic Disease

(Rac)-OSMI-1 is the racemate of OSMI-1. OSMI-1 is a cell-permeable O-GlcNAc transferase (OGT) inhibitor with an IC50 value of 2.7 μM. OSMI-1 inhibits protein O-linked N-acetylglucosamine (O-GlcNAcylation) in several mammalian cell lines without qualitatively altering cell surface N- or O-linked glycans .
loading...
    loading...
Cat. No.: HY-134902
CAS No.: 537039-67-1
Synonyms: UDP-α-6N3-glucose; 6-Azidoglucose-UDP
UDP-6-azido-6-Deoxy-D-Glc (UDP-α-6N3-glucose; 6-Azidoglucose-UDP) is a UDP-sugar donor . UDP-6-azido-6-Deoxy-D-Glc is used for the selective labeling of 5-hmC in genomic DNA. UDP-6-azido-6-Deoxy-D-Glc enables glyco-diversification modification of saponin intermediates and click chemistry-based derivatization .
loading...
    loading...
Cat. No.: HY-W477597
CAS No.: 1349070-58-1
Target:  

OGT

Research Areas:  

Others

BZX2 is an irreversible covalent inhibitor of O-GlcNAc transferase (OGT) with an IC50 of <10 µM. BZX2 is cell-permeable but exhibits multiple off-target effects .
loading...
    loading...
Cat. No.: HY-119738R
CAS No.: 1681056-61-0
Research Areas:  

Metabolic Disease

OSMI-1 (Standard) is the analytical standard of OSMI-1 (HY-119738). This product is intended for research and analytical applications. OSMI-1 is a cell-permeable O-GlcNAc transferase (OGT) inhibitor with an IC50 value of 2.7 μM. OSMI-1 inhibits protein O-linked N-acetylglucosamine (O-GlcNAcylation) in several mammalian cell lines without qualitatively altering cell surface N- or O-linked glycans .
loading...
    loading...
Cat. No.: HY-P80254
Synonyms: UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit, O-GlcNAc transferase subunit p110, O-linked N-acetylglucosamine transferase 110 kDa subunit, OGT

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF, IP, FC

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P87524
Synonyms: UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit, O-GlcNAc transferase subunit p110, O-linked N-acetylglucosamine transferase 110 kDa subunit, OGT

Host:  

Rabbit

Application:  

WB, IHC-P, IHC-F, IF-Tissue, FC, ICC/IF

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-134902A
Synonyms: UDP-α-6N3-glucose disodium; 6-Azidoglucose-UDP disodium
UDP-6-azido-6-Deoxy-D-Glc disodium (UDP-α-6N3-glucose; 6-Azidoglucose-UDP disodium) is a UDP-sugar donor . UDP-6-azido-6-Deoxy-D-Glc disodium is used for the selective labeling of 5-hmC in genomic DNA. UDP-6-azido-6-Deoxy-D-Glc disodium enables glyco-diversification modification of saponin intermediates and click chemistry-based derivatization .
loading...
    loading...
Cat. No.: HY-W699962
CAS No.: 137766-83-7
Target:  

Drug Intermediate

Research Areas:  

Metabolic Disease

Ac4GlcNAcF3 is a cell-permeable glycomimetic that can be recognized and utilized by OGT and is resistant to hydrolysis by OGA. GlcNAcF3, the active metabolite of Ac4GlcNAcF3, can be recognized by OGT as a substrate for peptide modification. Ac4GlcNAcF3 upregulates the level of cellular O-GlcNAc modification. Ac4GlcNAcF3 can be used in studies related to glycosylation regulation .
loading...
    loading...
  • 1